Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin

Abstract

Infection with Helicobacter pylori and the use of non-steroidal anti-inflammatory drugs (NSAIDs) are recognized as the two primary factors in the etiology of gastric disease. In this study, we applied the animal model of H. pylori-induced gastritis to assess the influence of NSAIDs on the course of mucosal inflammatory responses to H. pylori. Two days following intragastric application of H. pylori lipopolysaccharide, rats were divided into groups and administered daily for up to 8 days either indomethacin, aspirin or the vehicle, and their gastric mucosal tissue subjected to histological and biochemical assessment. H. pylori lipopolysaccharide elicited within 2 days a pattern of acute mucosal inflammatory responses accompanied by a massive epithelial cell apoptosis, and a marked increase in the expression of membrane-bound and soluble forms of TNF-α. The extent of mucosal inflammatory involvement reached a maximum by the 4th day and showed a decline by the 10th day; this was reflected in a 38.1% reduction in apoptosis, a 53.2% decline in membrane-bound TNF-α and a 63.8% decrease in soluble TNF-α. Compared to the vehicle controls, aspirin caused a 36.2% increase in the severity of the mucosal inflammatory involvement by the second day of administration and a 25.9% increase in the inflammatory involvement occurred by the 8th day; this effect of aspirin was accompanied by a significant (54.5%) induction in apoptosis, a 58.2% decline in membrane-bound TNF-α and a 61% increase in soluble TNF-α. In contrast, administration of indomethacin evoked only a marginal increase (5—7%) in apoptosis, and caused no discernible changes in the severity of gastric mucosal involvement and the expression of TNF-α forms elicited by H. pylori lipopolysaccharide. The findings indicate that aspirin, but not indomethacin, increases the severity of gastric mucosal inflammatory responses to H. pylori. This detrimental influence of aspirin appears to result from up-regulation in the mucosal expression of soluble form of TNF-α, which leads to the amplification of apoptotic events that potentiate gastric mucosal inflammatory reaction to H. pylori.

References

Stolte M. , Edit S. Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol 1996; 31 (Suppl. 214): 13—16.

Rune SJ History of Helicobacter infection. Scand J Gastroenterol 1996; 31 (Suppl 214): 2—4.

Eaker EY

Gastrointestinal injury related to the use of nonsteroidal anti-inflammatory drugs. Gastrointestinal Dis

Today 1997; 6: 1—8.

McCarthy DM

Nonsteroidal anti-inflammatory drugs: reducing the risk to gastrointestinal tract. Clin Perspect

Gastroenterol 1999; 2: 219—226.

Hawkey CJ Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000; 119: 521—535.

McCarthy DM Mechanism of mucosal injury and healing: the role of nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol 1995; 30 (Suppl 208): 24—29.

Marshall BJ Helicobacter pylori. Am J Gastroenterol 1994 ; 89: S116—S128.

National Institutes of Health, Office of the Director. NIH Consensus Statement: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65—69.

Herz R. , Schaube J. , Meining A. , Stolte M. Gastritis associated with Crohn disease can be masked by Helicobacter pylori gastritis. Scand J Gastroenterol 1999; 34: 471—473.

10.

Gabryelewicz A. Critical evaluation of the treatment of peptic ulcer diseases associated with H. pylori infection. J Physiol Pharmacol 1996; 47: 51—58.

11.

Tytgat Gnj. Current indications for Helicobacter pylori eradication therapy. Scand J Gastroenterol 1966; 31 (Suppl 215): 70—75.

12.

Unge P. Review of Helicobacter pylori eradication regimens. Scand J Gastroenterol 1996; 31 (Suppl 215): 76—81.

13.

Bianchi Porro G , Lazzaroni M. The conflicting relationship between Helicobacter pylori and nonsteroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1999; 34: 225—228.

14.

Labenz J. , Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19—23.

15.

Pilotto A. , Leandro G. , Mario FD , Fanceschi M. , Bozzola L. , Valerio G. Role of Helicobacter pylori infection on upper gastrontestinal bleeding in the elderly. Dig Dis Sci 1997; 42: 586—591.

16.

Cullen Dje , Hawkey GM , Greenwood DC et al. Peptic ulcer bleeding: relative roles of Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Gut 1997; 41: 459—462.

17.

Wu CY , Poon SK , Chen GH , Chang CS , Yeh HZ Interaction between Helicobacter pylori and nonsteroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1999; 33: 234—237.

18.

Aalykke C. , Lauritsen JM , Halls J. , Reinholdt S. , Krogfelt K. , Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999; 116: 1305—1309.

19.

Labenz J. , Peitz U. , Kohl H. et al. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-controlled study. Ital J Gastroenterol Hepatol 1999; 31: 110—114.

20.

Kopp E. , Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 264: 956—959.

21.

Yamamoto Y. , Yin MJ , Lin KM , Gaynor RB Sulindac inhibits activation of the NF-κ B pathway. J Biol Chem 1999; 274: 27307—27314.

22.

Lehmann JM , Lenhard JM , Oliver BB , Ringold GM , Kliewer SA Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 1997; 272: 3406—3410.

23.

Paik JH , Ju JH , Lee JY , Boudreau MD , Hwang DH Two opposing effects of nonsteroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. J Biol Chem 2000; 275: 28173—28179.

24.

Piotrowski J. , Piotrowski E. , Skrodzka D. , Slomiany A. , Slomiany BL Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 1997; 32: 203—211.

25.

Swantek JL , Christerson L. , Cobb MH Lipopolysaccharide-induced tumor necrosis factor-α promotor is inhibitor of nuclear factor-κB kinase-dependent. J Biol Chem 1999; 274: 11667—11671.

26.

Robache-Gallea S. , Morand V. , Burneau JM et al. In vitro processing of human tumor necrosis factor-α. J Biol Chem 1995; 270: 23688—23692.

27.

Reddy P. , Slack JL , Davis R. et al. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J Biol Chem 2000; 275: 14608—14614.

28.

Brinkman Bmn , Telliez JB , Schievella AR , Lin LL , Goldfeldt AE Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2- and p38 mitogen-activated protein kinase-dependent TNF-α gene expression. J Biol Chem 1999 ; 274: 30882—30886.

29.

Nowak M. , Gaines GC , Rosenberg J. et al. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor. Am J Physiol Regulatory Integrative Comp Physiol 2000; 278: R1202—R1209.

30.

Slomiany BL , Piotrowski J. , Slomiany A. Up-regulation of endothelin-converting enzyme-1 in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide . Biochem Biophys Res Commun 2000; 267: 801—805.

31.

Takeuchi K. , Suzuki K. , Yamamoto H. , Araki H. , Mizoguchi H. , Ukawa H. Cyclooxygenase-2-selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses. J Physiol Pharmacol 1998; 49: 501—513.

32.

Suzuki N. , Takahashi S. , Okabe S. Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol 1998; 49: 515—527.

33.

Price AB Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209—222.

34.

Rauws Eaj , Langenberg W. , Houthoff H. , Zanen MC , Tytgat Gnj. Campylobacter pylori-associated chronic active antral gastritis: a prospective study of its prevalence and the effect of antibacterial and antiulcer treatment . Gastroenterology 1988; 94: 33—40.

35.

Carter SR , Slomiany A. , Gwozdzinski K. , Liau YH , Slomiany BL Effect of ethanol on mucus glycoprotein sulfotransferase from gastric mucosa . J Biol Chem 1988; 263: 11977—11984.

36.

Slomiany BL , Piotrowski J. , Slomiany A. Effect of ebrotidine on Helicobacter pylori lipopolysaccharide-induced up-regulation of endothelin-1 in gastric mucosa. J Endotoxin Res 1999; 5: 279—285.

37.

Galanos C. , Luderlitz O. , Westphal O. A new method for the extraction of R lipopolysaccharide. Eur J Biochem 1969; 9: 245—249.

38.

Jirillo E. , Pece S. , Pellegrino NM et al. The role of Helicobacter pylori LPS in the pathogenesis of H. pylori-related gastropathy. J Endotoxin Res 1999; 5: 222—226.

39.

Pece S. , Fumarola D. , Giuliani G. , Jirillo E. , Moran AP Activity in Limulus amebocyte lysate assay and induction of tumor necrosis factor-α by diverse Helicobacter pylori lipopolysaccharide preparations . J Endotoxin Res 1995; 2: 455—462.

40.

Piotrowski J. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents. J Physiol Pharmacol 1998; 49: 3—24.

41.

Park YC , Ye H. , Hsia C. et al. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 2000; 101: 777—787.

42.

Delhase M. , Hayakawa M. , Chen Y. , Karin M. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 1999; 284: 309—313.

43.

Phelps CB , Sengchanthalangasy LL , Huxford T. , Ghosh G. mechanism of IκBα binding to NF-κB dimers. J Biol Chem 2000; 275: 29840—29846.